CVAC logo

CureVac NV (CVAC) Company Overview

Profile

Full Name:

CureVac N.V.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Germany

IPO:

August 14, 2020

Indexes:

Not included

Description:

CureVac NV is a biotechnology company focused on developing mRNA-based therapies and vaccines. They aim to treat diseases by using messenger RNA to instruct cells to produce proteins that can help the body fight infections and cancer. Their innovative approach targets various medical needs.

Key Details

Price

$3.06

Annual Revenue

$58.20 M(-18.15% YoY)

Annual EPS

-$1.28(+8.23% YoY)

Annual ROE

-49.27%

Beta

1.37

Events Calendar

Earnings

Next earnings date:

Apr 24, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Apr 24, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 14, 25 JMP Securities
Market Outperform
Sep 16, 24 JMP Securities
Market Outperform
Aug 16, 24 JMP Securities
Market Outperform
Jul 3, 24 JMP Securities
Market Outperform
Apr 25, 24 Leerink Partners
Market Perform
Apr 5, 24 Guggenheim
Neutral
Dec 31, 21 Deutsche Bank
Hold
Oct 22, 21 Deutsche Bank
Hold
Jun 17, 21 B of A Securities
Neutral
Apr 26, 21 Guggenheim
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for CureVac NV?
  • Does CureVac NV pay dividends?
  • What sector is CureVac NV in?
  • What industry is CureVac NV in?
  • What country is CureVac NV based in?
  • When did CureVac NV go public?
  • Is CureVac NV in the S&P 500?
  • Is CureVac NV in the NASDAQ 100?
  • Is CureVac NV in the Dow Jones?
  • When was CureVac NV's last earnings report?
  • When does CureVac NV report earnings?

What is the ticker symbol for CureVac NV?

The ticker symbol for CureVac NV is NASDAQ:CVAC

Does CureVac NV pay dividends?

No, CureVac NV does not pay dividends

What sector is CureVac NV in?

CureVac NV is in the Healthcare sector

What industry is CureVac NV in?

CureVac NV is in the Biotechnology industry

What country is CureVac NV based in?

CureVac NV is headquartered in Germany

When did CureVac NV go public?

CureVac NV's initial public offering (IPO) was on August 14, 2020

Is CureVac NV in the S&P 500?

No, CureVac NV is not included in the S&P 500 index

Is CureVac NV in the NASDAQ 100?

No, CureVac NV is not included in the NASDAQ 100 index

Is CureVac NV in the Dow Jones?

No, CureVac NV is not included in the Dow Jones index

When was CureVac NV's last earnings report?

CureVac NV's most recent earnings report was on Nov 12, 2024

When does CureVac NV report earnings?

The next expected earnings date for CureVac NV is Apr 24, 2025